A variable diameter intermediate conduit
By designing a variable-diameter intermediate catheter, the problem of the intermediate catheter being unable to penetrate deeply into tortuous and small blood vessels was solved, achieving stable insertion and efficient thrombus removal in tortuous blood vessels, reducing operation time and embolism risk.
Patent Information
- Application Number
- CN202410487921.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-23
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2044-04-23
AI Technical Summary
Commercially available intermediate catheters cannot penetrate deep into tortuous and small blood vessels, and cannot provide sufficient support, making surgery difficult and thus having poor applicability.
A variable-diameter intermediate catheter was designed, with the inner and outer diameters of the catheter gradually decreasing from the proximal end to the distal end. It is equipped with a microcatheter connector, a hemostatic valve cap, and a stress-buffered sleeve. It is manufactured through rheological and injection molding processes, using high-molecular polymers and stainless steel braided mesh to provide sufficient support and reduce surgical steps.
It improves the applicability of intermediate catheters in tortuous and small blood vessels, reduces operation time and the risk of vascular embolism, and facilitates thrombus removal.
Smart Images

Figure CN118203390B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of variable diameter intermediate conduit technology, and in particular to a variable diameter intermediate conduit. Background Technology
[0002] A variable-diameter intermediate catheter is a commonly used medical device, usually used in conjunction with medical imaging equipment to mechanically remove blood clots blocking blood vessels or to dissolve blood clots with drugs.
[0003] When using intermediate catheters to treat patients with blood vessels blocked by thrombi, the intermediate catheter is inserted into the catheter sheath percutaneously under the monitoring of medical imaging equipment. This assists the thrombolytic device in reaching the proximal end of the blood vessel thrombus, and then the thrombus is removed. However, because commercially available intermediate catheters cannot penetrate deep into tortuous and small blood vessels and cannot provide sufficient support for the thrombolytic device, the surgery is difficult to perform. Therefore, they cannot meet the needs of different patient locations, resulting in poor applicability. Summary of the Invention
[0004] This invention proposes a variable-diameter intermediate catheter to address the problem that commercially available intermediate catheters cannot penetrate deep into tortuous and small blood vessels, cannot provide sufficient support for thrombolytic devices, making surgery difficult and thus failing to meet the needs of different patient locations, resulting in poor applicability.
[0005] To achieve the above objectives, the present invention adopts the following technical solution: a variable diameter intermediate catheter, comprising a microcatheter connector, a hemostatic valve cap, and an intermediate catheter body. One end of the microcatheter connector is provided with a second 6% Luer connector, and the end of the microcatheter connector away from the second 6% Luer connector is fixedly connected to a first stress buffer sleeve. The inner wall of the first stress buffer sleeve is fixedly connected to the microcatheter body, and the outer surface of one end of the intermediate catheter body is fixedly connected to a second stress buffer sleeve. The inner and outer diameters of the intermediate catheter body gradually decrease from the proximal end to the distal end. The size and shape of the inner walls of the second stress buffer sleeve and the intermediate catheter body are adapted to the size and shape of the outer surface of the microcatheter body.
[0006] The effects achieved by the above components are as follows: During percutaneous catheter sheath insertion, the catheter sheath is inserted, and under X-ray guidance, the guidewire is advanced first, and the intermediate catheter body is inserted into the target location in the patient's blood vessel. Then, the microcatheter connector is held, and the microcatheter body on one end of the first stress buffer sheath is moved from the inner wall of the intermediate catheter body to the treatment position. After insertion, the medication is administered through the second 6% Luer connector to the inside of the microcatheter connector, injecting thrombolytic drugs until the thrombus is completely cleared. Because the inner and outer diameters of the intermediate catheter body are set to gradually decrease from the proximal end to the distal end, the variable diameter intermediate catheter body can be inserted into tortuous and small blood vessels, and the auxiliary microcatheter body provides sufficient support, thereby improving the usability of the intermediate catheter body.
[0007] Preferably, a hollow rod is fixedly connected to one side of the inner wall of the hemostatic valve cover, and the inner wall of the hollow rod is connected to the inner wall of one end of the hemostatic valve cover. Several elastic blocks are fixedly connected to one side of the hemostatic valve cover, and a hemostatic valve body is connected to one end of the hemostatic valve cover by the elastic blocks. A circular groove is opened on one side of the hemostatic valve body, and a silicone sheet is fixedly connected to the inner wall of the circular groove. The inner wall of one end of the hemostatic valve body is fixedly connected to the outer surface of one end of the second stress buffer sleeve. The size and shape of the inner walls of the hemostatic valve cover, the hollow rod, and the hemostatic valve body are all adapted to the size and shape of the outer surface of the microcatheter body.
[0008] The effects achieved by the above components are as follows: by placing the hemostatic valve body on the intermediate catheter body, the operation steps of connecting the external hemostatic valve can be reduced, the operation time can be reduced, and the risk of vascular embolism caused by incomplete gas removal can be reduced. It can also improve the usability of the intermediate catheter body, making it easier to insert it into tortuous and small blood vessels to remove thrombi inside.
[0009] Preferably, a groove is provided on one side of the hemostatic valve cover, the inner wall of the groove is connected to the inner wall of the hemostatic valve body, and the size and shape of the inner wall of the groove are adapted to the size and shape of the outer surface of one end of the first stress buffer sleeve.
[0010] The effect achieved by the above-mentioned components is as follows: by setting the groove, when the microcatheter body is inserted into the hemostatic valve cover to a certain position for use, one end of the first stress buffer sleeve will abut into the groove, making it less prone to shaking and improving the stability of the microcatheter body operation.
[0011] Preferably, a first 6% Luer connector is fixedly connected above the outer surface of the hemostatic valve body, and the inner wall of the first 6% Luer connector is connected to the inner wall of the hemostatic valve body.
[0012] The effect achieved by the above-mentioned components is that, by setting the first 6% Luer connector, when the intermediate catheter is inserted into the patient's body for surgery, other injection devices can be connected to the first 6% Luer connector during the operation, which facilitates the secondary injection of drugs.
[0013] Preferably, the microcatheter connector, the first stress buffer sleeve, the second stress buffer sleeve, and the hemostatic valve body are all manufactured by injection molding, and the microcatheter body and the intermediate catheter body are manufactured by rheological processes.
[0014] The effects achieved by the above components are as follows: the rheological process has the advantages of saving energy, short process, low production cost and high production efficiency, which facilitates the processing of the microcatheter body and intermediate catheter body; the injection molding process has the advantages of high production efficiency and high molding precision, which improves the quality of the microcatheter connector, the first stress buffer sleeve, the second stress buffer sleeve and the hemostatic valve body itself.
[0015] Preferably, both the microcatheter body and the intermediate catheter body are three-layered, with the innermost and outermost layers of the microcatheter body and the intermediate catheter body being made of high molecular polymer material, and the middle layer of the microcatheter body and the intermediate catheter body being made of stainless steel woven mesh.
[0016] The effects achieved by the above components are as follows: the innermost and outermost layers of the microcatheter body and the intermediate catheter body are made of high molecular polymer, which allows it to deform accordingly with the shape of the blood vessel after insertion into the blood vessel. The stainless steel braided mesh in the middle layer can support the inner wall of the microcatheter body and the intermediate catheter body, making it less likely to be flattened and affect the subsequent drug delivery.
[0017] Preferably, both the first stress buffer sleeve and the second stress buffer sleeve are made of high molecular polymer material, and the connection between the first stress buffer sleeve and the microcatheter body and the connection between the second stress buffer sleeve and the intermediate catheter body are fixedly connected by heat shrinking process.
[0018] The aforementioned components achieve the following effects: they can effectively prevent breakage at the connection between the microcatheter body and the microcatheter connector, and prevent breakage at the connection between the intermediate catheter body and the hemostatic valve body, thereby improving the connection strength.
[0019] Preferably, a through slit is provided on one side of the silicone sheet, and the cross-section of the through slit is cross-shaped.
[0020] The effect achieved by the above components is that by setting through slits, the microcatheter body can pass through easily while the inner wall of its silicone sheet can be tightly attached to the outer surface of the microcatheter body to seal its outer surface.
[0021] In summary, the beneficial effects of the present invention are as follows:
[0022] In the percutaneous catheterization technique, the catheter sheath is inserted, and under X-ray guidance, the guidewire is advanced first, and the intermediate catheter body is inserted into the target location in the patient's blood vessel. Then, the microcatheter connector is held, and the microcatheter body on one end of the first stress buffer sheath is moved from the inner wall of the intermediate catheter body to the treatment position. After insertion, the medication is administered through the second 6% Luer connector, injecting thrombolytic solution until the thrombus is completely cleared. Because the inner and outer diameters of the intermediate catheter body are set to gradually decrease from the proximal end to the distal end, the variable diameter intermediate catheter body can be inserted into tortuous and small blood vessels, and the auxiliary microcatheter body provides sufficient support, thereby improving the usability of the intermediate catheter body. By setting the hemostatic valve body on the intermediate catheter body, the operation steps of external hemostatic valve can be reduced, the operation time can be reduced, and the risk of vascular embolism caused by incomplete gas removal can be reduced. This improves the usability of the intermediate catheter body and makes it easier to insert it into tortuous and small blood vessels to remove internal thrombi. Attached Figure Description
[0023] Figure 1 This is a three-dimensional schematic diagram of the microcatheter connector of the present invention;
[0024] Figure 2 This is a three-dimensional schematic diagram of the first stress buffer sleeve of the present invention;
[0025] Figure 3 yes Figure 2 A three-dimensional cross-sectional view of the hemostasis valve body;
[0026] Figure 4 yes Figure 2 A three-dimensional cross-sectional view of the second stress buffer sleeve in the middle section;
[0027] Figure 5 yes Figure 2 A three-dimensional cross-sectional view of the middle conduit body;
[0028] Figure 6 This is a three-dimensional schematic diagram of the hollow rod of the present invention;
[0029] Figure 7 This is a three-dimensional schematic diagram of the hemostatic valve body of the present invention;
[0030] Figure 8 This is a cross-sectional view of the microcatheter body of the present invention;
[0031] Figure 9 This is a cross-sectional view of the intermediate conduit body of the present invention.
[0032] Explanation of reference numerals in the attached figures:
[0033] 1. Microcatheter connector; 2. First stress buffer sleeve; 3. Microcatheter body; 4. Hemostatic valve cap; 5. Hollow rod; 6. Elastic locking block; 7. Hemostatic valve body; 8. First 6% Luer connector; 9. Circular groove; 10. Silicone sheet; 11. Through slit; 12. Second stress buffer sleeve; 13. Intermediate catheter body; 14. Groove; 15. Second 6% Luer connector. Detailed Implementation
[0034] Reference Figure 1-9 As shown, this embodiment discloses a variable diameter intermediate catheter, including a microcatheter connector 1, a hemostatic valve cap 4, and an intermediate catheter body 13. The microcatheter connector 1 has a second 6% Luer connector 15 at one end, a first stress buffer sleeve 2 fixedly connected to the end of the microcatheter connector 1 away from the second 6% Luer connector 15, a microcatheter body 3 fixedly connected to the inner wall of the first stress buffer sleeve 2, and a second stress buffer sleeve 12 fixedly connected to the outer surface of one end of the intermediate catheter body 13. The inner and outer diameters of the intermediate catheter body 13 gradually decrease from the proximal end to the distal end. The size and shape of the inner walls of the second stress buffer sleeve 12 and the intermediate catheter body 13 are adapted to the size and shape of the outer surface of the microcatheter body 3. In the percutaneous catheter sheath insertion technique, the catheter sheath is inserted, and under X-ray guidance, the guidewire is advanced first, and the intermediate catheter body 13 is inserted into the target position in the patient's blood vessel. Then, the microcatheter connector 1 is held and the microcatheter body 3 on one end of the first stress buffer sheath 2 is moved from the inner wall of the intermediate catheter body 13 to the treatment position. After insertion, the drug is administered through the second 6% Luer connector 15 into the inside of the microcatheter connector 1, injecting thrombolytic solution until the thrombus is completely cleared. Because the inner and outer diameters of the intermediate catheter body 13 are set to gradually decrease from the proximal end to the distal end, the variable diameter intermediate catheter body 13 can be inserted into tortuous and small blood vessels, and the auxiliary microcatheter body 3 provides sufficient support, thereby improving the usability of the intermediate catheter body 13.
[0035] Reference Figure 1-9As shown, this embodiment discloses a hollow rod 5 fixedly connected to one side of the inner wall of the hemostatic valve cover 4. The inner wall of the hollow rod 5 is connected to the inner wall of one end of the hemostatic valve cover 4. Several elastic blocks 6 are fixedly connected to one side of the hemostatic valve cover 4. One end of the hemostatic valve cover 4 is connected to the hemostatic valve body 7 by the elastic blocks 6. A circular groove 9 is opened on one side of the hemostatic valve body 7. A silicone sheet 10 is fixedly connected to the inner wall of the circular groove 9. One end of the inner wall of the hemostatic valve body 7 is fixedly connected to the outer surface of one end of the second stress buffer sleeve 12. The size and shape of the inner walls of the hemostatic valve cover 4, the hollow rod 5, and the hemostatic valve body 7 are all adapted to the size and shape of the outer surface of the microcatheter body 3. Insert the intermediate catheter body 13 into the target location in the patient's blood vessel. Press the hemostatic valve cover 4, causing one end of the hollow rod 5 inside to push open the inside of the silicone sheet 10. Then, hold the microcatheter connector 1 and insert the microcatheter body 3 on one end of the first stress buffer sleeve 2 through the inner wall of the hemostatic valve cover 4, so that it reaches the treatment position through the hollow rod 5, the hemostatic valve body 7, and the inner wall of the intermediate catheter body 13. At this time, pull the hemostatic valve cover 4 backward, so that the hollow rod 5 inside is pulled out from inside the silicone sheet 10. When the inner wall of the silicone sheet 10 rebounds, it will clamp the outer surface of the microcatheter body 3, preventing blood in the blood vessel from flowing back from the intermediate catheter, which could cause the catheter to become blocked and affect the operation. By setting the hemostatic valve body 7 on the intermediate catheter body 13, the operation steps of connecting the external hemostatic valve can be reduced, the operation time can be reduced, and the risk of vascular embolism caused by incomplete gas removal can be reduced. This can improve the usability of the intermediate catheter body 13, making it easier to insert it into tortuous and small blood vessels to remove thrombi inside.
[0036] Reference Figure 1-9 As shown in the figure, this embodiment discloses a groove 14 on one side of the hemostatic valve cover 4. The inner wall of the groove 14 is connected to the inner wall of the hemostatic valve body 7. The size and shape of the inner wall of the groove 14 are adapted to the size and shape of the outer surface of one end of the first stress buffer sleeve 2. By setting the groove 14, when the microcatheter body 3 is inserted into the hemostatic valve cover 4 to a certain position for use, one end of the first stress buffer sleeve 2 will abut into the groove 14, making it less prone to shaking and improving the stability of the microcatheter body 3 during operation.
[0037] Reference Figure 1-9As shown, this embodiment discloses a first 6% Luer connector 8 fixedly connected above the outer surface of the hemostatic valve body 7, with the inner wall of the first 6% Luer connector 8 communicating with the inner wall of the hemostatic valve body 7. By providing the first 6% Luer connector 8, during surgery when the intermediate catheter body 13 is inserted into the patient's body, other injection devices can be connected to the first 6% Luer connector 8 to facilitate secondary drug injection. The microcatheter connector 1, the first stress buffer sleeve 2, the second stress buffer sleeve 12, and the hemostatic valve body 7 are all manufactured using injection molding, while the microcatheter body 3 and the intermediate catheter body 13 are manufactured using rheological processes. Rheological processes offer advantages such as energy saving, short process time, low production cost, and high production efficiency, facilitating the processing of the microcatheter body 3 and the intermediate catheter body 13. Injection molding offers advantages such as high production efficiency and high molding precision, improving the quality of the microcatheter connector 1, the first stress buffer sleeve 2, the second stress buffer sleeve 12, and the hemostatic valve body 7.
[0038] Reference Figure 1-9 As shown in the illustration, this embodiment discloses a three-layered microcatheter body 3 and an intermediate catheter body 13. The innermost and outermost layers of both the microcatheter body 3 and the intermediate catheter body 13 are made of polymer material, while the middle layer is a stainless steel braided mesh. The polymer material in the innermost and outermost layers allows the microcatheter body 3 and the intermediate catheter body 13 to deform according to the shape of the blood vessel after insertion. The stainless steel braided mesh in the middle layer supports the inner wall of the microcatheter body 3 and the intermediate catheter body 13, preventing them from being flattened and affecting subsequent drug delivery.
[0039] Reference Figure 1-9 As shown in the figure, this embodiment discloses that both the first stress buffer sleeve 2 and the second stress buffer sleeve 12 are made of high molecular polymer material. The connection between the first stress buffer sleeve 2 and the microcatheter body 3, and the connection between the second stress buffer sleeve 12 and the intermediate catheter body 13, are fixedly connected by a heat shrink process. This can effectively prevent breakage at the connection between the microcatheter body 3 and the microcatheter connector 1, and prevent breakage at the connection between the intermediate catheter body 13 and the hemostatic valve body 7, thereby improving the connection firmness.
[0040] Reference Figure 1-9 As shown, this embodiment discloses a through slit 11 on one side of the silicone sheet 10, and the cross-section of the through slit 11 is cross-shaped. By setting the through slit 11, the microcatheter body 3 can pass through easily, while the inner wall of the silicone sheet 10 can be tightly attached to the outer surface of the microcatheter body 3 to seal its outer surface.
[0041] The working principle is as follows: During percutaneous catheter sheath insertion, the catheter sheath is inserted. Under X-ray guidance, the guidewire is advanced first, and the intermediate catheter body 13 is inserted into the target location within the patient's blood vessel. The hemostatic valve cap 4 is pressed, causing one end of the internal hollow rod 5 to push open the interior of the silicone sheet 10. Then, the microcatheter connector 1 is held, and the microcatheter body 3 on one end of the first stress buffer sleeve 2 is inserted through the inner wall of the hemostatic valve cap 4, allowing it to pass through the hollow rod 5, the hemostatic valve body 7, and the inner wall of the intermediate catheter body 13 to reach the treatment position. At this point, the hemostatic valve cap 4 is pulled back, causing the internal hollow rod 5 to exit from the silicone sheet 10. When the inner wall of the silicone sheet 10 rebounds, it clamps the outer surface of the microcatheter body 3, preventing blood from flowing back from the intermediate catheter and causing blockage that could affect the procedure. After insertion, the second 6% Luer connector... The first 15 pairs of microcatheter connectors 1 and administers thrombolytic drugs until all thrombi are cleared. Because the inner and outer diameters of the intermediate catheter body 13 gradually decrease from the proximal end to the distal end, the variable-diameter intermediate catheter body 13 can be inserted into tortuous and small blood vessels, providing sufficient support to the microcatheter body 3. By placing the hemostatic valve on the intermediate catheter, the operation steps of connecting the external hemostatic valve are reduced, the operation time is reduced, and the risk of vascular embolism due to incomplete gas removal is reduced. This improves the usability of the intermediate catheter body 13, making it easier to insert into tortuous and small blood vessels to clear the thrombi inside. When the intermediate catheter body 13 is inserted into the patient's body for surgery, other injection devices can be connected to the first 6% Luer connector 8 during the operation to facilitate secondary drug injection.
Claims
1. A variable-diameter intermediate catheter, comprising a microcatheter connector (1), a hemostatic valve cap (4), and an intermediate catheter body (13), characterized in that: One end of the microcatheter connector (1) is provided with a second 6% Luer connector (15). The end of the microcatheter connector (1) away from the second 6% Luer connector (15) is fixedly connected to a first stress buffer sleeve (2). The inner wall of the first stress buffer sleeve (2) is fixedly connected to the microcatheter body (3). The outer surface of one end of the intermediate catheter body (13) is fixedly connected to a second stress buffer sleeve (12). The inner and outer diameters of the intermediate catheter body (13) gradually decrease from the proximal end to the distal end. The size and shape of the inner walls of the second stress buffer sleeve (12) and the intermediate catheter body (13) are adapted to the size and shape of the outer surface of the microcatheter body (3). The inner wall of the hemostatic valve cap (4) is... A hollow rod (5) is fixedly connected to the side. The inner wall of the hollow rod (5) is connected to the inner wall of one end of the hemostatic valve cover (4). Several elastic blocks (6) are fixedly connected to one side of the hemostatic valve cover (4). A hemostatic valve body (7) is connected to one end of the hemostatic valve cover (4) by the elastic blocks (6). A circular groove (9) is opened on one side of the hemostatic valve body (7). A silicone sheet (10) is fixedly connected to the inner wall of the circular groove (9). The inner wall of one end of the hemostatic valve body (7) is fixedly connected to the outer surface of one end of the second stress buffer sleeve (12). The size and shape of the inner walls of the hemostatic valve cover (4), the hollow rod (5), and the hemostatic valve body (7) are all adapted to the size and shape of the outer surface of the microcatheter body (3).
2. The variable diameter intermediate conduit according to claim 1, characterized in that: A groove (14) is provided on one side of the hemostatic valve cover (4). The inner wall of the groove (14) is connected to the inner wall of the hemostatic valve body (7). The size and shape of the inner wall of the groove (14) are adapted to the size and shape of the outer surface of one end of the first stress buffer sleeve (2).
3. The variable diameter intermediate conduit according to claim 1, characterized in that: A first 6% Luer connector (8) is fixedly connected above the outer surface of the hemostatic valve body (7), and the inner wall of the first 6% Luer connector (8) is connected to the inner wall of the hemostatic valve body (7).
4. The variable diameter intermediate conduit according to claim 1, characterized in that: The microcatheter connector (1), the first stress buffer sleeve (2), the second stress buffer sleeve (12) and the hemostatic valve body (7) are all made by injection molding, and the microcatheter body (3) and the intermediate catheter body (13) are all made by rheological process.
5. A variable diameter intermediate conduit according to claim 1, characterized in that: Both the microcatheter body (3) and the intermediate catheter body (13) are three-layered tubes. The innermost and outermost layers of the microcatheter body (3) and the intermediate catheter body (13) are made of polymer materials, and the middle layer of the microcatheter body (3) and the intermediate catheter body (13) is made of stainless steel woven mesh.
6. A variable diameter intermediate conduit according to claim 1, characterized in that: The first stress buffer sleeve (2) and the second stress buffer sleeve (12) are both made of high molecular polymer material. The connection between the first stress buffer sleeve (2) and the microcatheter body (3) and the connection between the second stress buffer sleeve (12) and the intermediate catheter body (13) are fixedly connected by heat shrinking process.
7. A variable diameter intermediate conduit according to claim 1, characterized in that: The silicone sheet (10) has a through slit (11) on one side, and the cross-section of the through slit (11) is cross-shaped.
Citation Information
Patent Citations
Double-balloon micro catheter with side holes
CN219185524U
Systems, apparatus and methods for removing and filtering vessel occlusions to isolate blood for reinfusion into a patient
US20240016505A1
